{"nct_id":"NCT02655822","title":"Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers","status":"COMPLETED","status_verified_date":"2021-07","start_date":"2016-01","start_date_type":null,"primary_completion_date":"2021-06","primary_completion_date_type":"ACTUAL","completion_date":"2021-07","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["CRVS"]}